91 related articles for article (PubMed ID: 31662298)
1. Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.
Lopez CK; Noguera E; Stavropoulou V; Robert E; Aid Z; Ballerini P; Bilhou-Nabera C; Lapillonne H; Boudia F; Thirant C; Fagnan A; Arcangeli ML; Kinston SJ; Diop M; Job B; Lecluse Y; Brunet E; Babin L; Villeval JL; Delabesse E; Peters AHFM; Vainchenker W; Gaudry M; Masetti R; Locatelli F; Malinge S; Nerlov C; Droin N; Lobry C; Godin I; Bernard OA; Göttgens B; Petit A; Pflumio F; Schwaller J; Mercher T
Cancer Discov; 2019 Dec; 9(12):1736-1753. PubMed ID: 31662298
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Transcriptome Profiling of Cryptic
Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
[TBL] [Abstract][Full Text] [Related]
3. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
Aid Z; Robert E; Lopez CK; Bourgoin M; Boudia F; Le Mene M; Riviere J; Baille M; Benbarche S; Renou L; Fagnan A; Thirant C; Federici L; Touchard L; Lecluse Y; Jetten A; Geoerger B; Lapillonne H; Solary E; Gaudry M; Meshinchi S; Pflumio F; Auberger P; Lobry C; Petit A; Jacquel A; Mercher T
Leukemia; 2023 Mar; 37(3):571-579. PubMed ID: 36585521
[TBL] [Abstract][Full Text] [Related]
4. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract][Full Text] [Related]
5. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.
Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
[TBL] [Abstract][Full Text] [Related]
6. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Hoffmeister LM; Suttorp J; Walter C; Antoniou E; Behrens YL; Göhring G; Awada A; von Neuhoff N; Reinhardt D; Schneider M
Leukemia; 2024 Mar; 38(3):538-544. PubMed ID: 38086945
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.
Al-Matary YS; Botezatu L; Opalka B; Hönes JM; Lams RF; Thivakaran A; Schütte J; Köster R; Lennartz K; Schroeder T; Haas R; Dührsen U; Khandanpour C
Haematologica; 2016 Oct; 101(10):1216-1227. PubMed ID: 27390361
[TBL] [Abstract][Full Text] [Related]
8. Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia.
Tsuzuki S; Yasuda T; Kojima S; Kawazu M; Akahane K; Inukai T; Imaizumi M; Morishita T; Miyamura K; Ueno T; Karnan S; Ota A; Hyodo T; Konishi H; Sanada M; Nagai H; Horibe K; Tomita A; Suzuki K; Muramatsu H; Takahashi Y; Miyazaki Y; Matsumura I; Kiyoi H; Hosokawa Y; Mano H; Hayakawa F
Blood Cancer Discov; 2020 Jul; 1(1):82-95. PubMed ID: 34661142
[TBL] [Abstract][Full Text] [Related]
9. Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation.
Mendoza-Castrejon J; Magee JA
Immunol Rev; 2023 May; 315(1):197-215. PubMed ID: 36588481
[TBL] [Abstract][Full Text] [Related]
10. [Acute myeloid leukemia with positive PICAML-MLLT10 fusion gene: report of 4 cases and literature review].
Hu DY; Shen K; Guo YS; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):687-689. PubMed ID: 37803846
[No Abstract] [Full Text] [Related]
11. The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.
Kugler E; Madiwale S; Yong D; Thoms JAI; Birger Y; Sykes DB; Schmoellerl J; Drakul A; Priebe V; Yassin M; Aqaqe N; Rein A; Fishman H; Geron I; Chen CW; Raught B; Liu Q; Ogana H; Liedke E; Bourquin JP; Zuber J; Milyavsky M; Pimanda J; Privé GG; Izraeli S
Nat Commun; 2023 Sep; 14(1):5871. PubMed ID: 37735473
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel ITGAX::RN7SL2 fusion in acute myelocytic leukemia.
Su Z; Cong B; Li X
Int J Lab Hematol; 2024 Jun; 46(3):577-579. PubMed ID: 38450977
[No Abstract] [Full Text] [Related]
13. Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators.
Bonilla G; Morris A; Kundu S; Ducasse A; Jeffries NE; Chetal K; Yvanovich EE; Barghout R; Scadden D; Mansour MK; Kingston RE; Sykes DB; Mercier FE; Sadreyev RI
bioRxiv; 2024 Mar; ():. PubMed ID: 38496490
[TBL] [Abstract][Full Text] [Related]
14. Targeting Chromatin Regulation in Acute Myeloid Leukemia.
Richardson SE; Huntly BJP
Hemasphere; 2021 Jun; 5(6):e589. PubMed ID: 34095772
[No Abstract] [Full Text] [Related]
15. The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model.
Bertuccio SN; Boudia F; Cambot M; Lopez CK; Lordier L; Donada A; Robert E; Thirant C; Aid Z; Serravalle S; Astolfi A; Indio V; Locatelli F; Pession A; Vainchenker W; Masetti R; Raslova H; Mercher T
Hemasphere; 2020 Feb; 4(1):e319. PubMed ID: 32072139
[No Abstract] [Full Text] [Related]
16. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention.
Mercher T; Schwaller J
Front Pediatr; 2019; 7():401. PubMed ID: 31681706
[TBL] [Abstract][Full Text] [Related]
18. Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.
Laurent AP; Siret A; Ignacimouttou C; Panchal K; Diop M; Jenni S; Tsai YC; Roos-Weil D; Aid Z; Prade N; Lagarde S; Plassard D; Pierron G; Daudigeos E; Lecluse Y; Droin N; Bornhauser BC; Cheung LC; Crispino JD; Gaudry M; Bernard OA; Macintyre E; Barin Bonnigal C; Kotecha RS; Geoerger B; Ballerini P; Bourquin JP; Delabesse E; Mercher T; Malinge S
Clin Cancer Res; 2020 Jul; 26(13):3307-3318. PubMed ID: 32220889
[TBL] [Abstract][Full Text] [Related]
19. Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy.
Forte D; García-Fernández M; Sánchez-Aguilera A; Stavropoulou V; Fielding C; Martín-Pérez D; López JA; Costa ASH; Tronci L; Nikitopoulou E; Barber M; Gallipoli P; Marando L; Fernández de Castillejo CL; Tzankov A; Dietmann S; Cavo M; Catani L; Curti A; Vázquez J; Frezza C; Huntly BJ; Schwaller J; Méndez-Ferrer S
Cell Metab; 2020 Nov; 32(5):829-843.e9. PubMed ID: 32966766
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Drivers and Development.
Cruz Hernandez D; Vyas P
Cancer Discov; 2019 Dec; 9(12):1653-1655. PubMed ID: 31792123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
